Intuitive Surgical (ISRG) shares dropped 12% despite beating second quarter expectations. EPS increased to $2.80, ahead of consensus of $2.50. Revenue rose to $2.89bn, also above forecasts. Investors appeared disappointed that full year procedure growth guidance remained unchanged at about 14%.